Galectin-9 in physiological and pathological conditions

被引:163
|
作者
Hirashima, M
Kashio, Y
Nishi, N
Yamauchi, A
Imaizumi, T
Kageshita, T
Saita, N
Nakamura, T
机构
[1] Kagawa Med Univ, Dept Immunol & Immunopathol, Miki, Kagawa 7610793, Japan
[2] Kagawa Med Univ, Dept Endocrinol, Miki, Kagawa 7610793, Japan
[3] Kagawa Med Univ, Dept Surg, Miki, Kagawa 7610793, Japan
[4] Hirosaki Univ, Sch Med, Inst brain Sci, Dept Vasc Biol, Hirosaki, Aomori 036, Japan
[5] Kumamoto Univ, Sch Med, Dept Dermatol, Kumamoto 860, Japan
[6] Kumamoto Univ, Sch Med, Dept Internal Med, Kumamoto 860, Japan
关键词
galectin-9 (Gal-9); eosinophil activation; cancer; apoptosis; prognosis;
D O I
10.1023/B:GLYC.0000014090.63206.2f
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We first cloned galectin-9 (Gal-9)/ecalectin as a T cell-derived eosinophil chemoattractant. Gal-9 plays a role in not only accumulation but also activation of eosinophils in experimental allergic models and human allergic patients, because Gal-9 induces eosinophil chemoattraction in vitro and in vivo and activates eosinophils in many aspects. Gal-9 requires divalent galactoside-binding activity but not the linker peptide of Gal-9 to exhibit its biological functions, and an unidentified matrix metalloproteinase is involved in the release of Gal-9. Our recent studies also showed that Gal-9 has other functions, such as cell differentiation, aggregation, adhesion, and death. Now, we and other groups are on the way of investigating the regulation and function of Gal-9 in a variety of physiological and pathological conditions. In this article, we will show the possible role of Gal-9 in physiological and pathological conditions by using our recent findings.
引用
收藏
页码:593 / 600
页数:8
相关论文
共 50 条
  • [41] Possible therapeutic applicability of galectin-9 in cutaneous T-cell lymphoma
    Nakajima, Rina
    Miyagaki, Tomomitsu
    Kamijo, Hiroaki
    Oka, Tomonori
    Shishido-Takahashi, Naomi
    Suga, Hiraku
    Sugaya, Makoto
    Sato, Shinichi
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2019, 96 (03) : 134 - 142
  • [42] Induction of apoptosis by Galectin-9 in liver metastatic cancer cells: In vitro study
    Tadokoro, Tomoko
    Fujihara, Shintaro
    Chiyo, Taiga
    Oura, Kyoko
    Samukawa, Eri
    Yamana, Yoshimi
    Fujita, Koji
    Mimura, Shima
    Sakamoto, Teppei
    Nomura, Takako
    Tani, Joji
    Yoneyama, Hirohito
    Morishita, Asahiro
    Himoto, Takashi
    Iwama, Hisakazu
    Niki, Toshiro
    Hirashima, Mitsuomi
    Masaki, Tsutomu
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 51 (02) : 607 - 614
  • [43] Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis
    Zhou, Xiaoxiang
    Sun, Lejia
    Jing, Dan
    Xu, Gang
    Zhang, Jinmei
    Lin, Li
    Zhao, Jingjing
    Yao, Zhuoran
    Lin, Hongfeng
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [44] Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target
    Zhang, Minpu
    Liu, Cun
    Li, Ye
    Li, Huayao
    Zhang, Wenfeng
    Liu, Jingyang
    Wang, Liquan
    Sun, Changgang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 11
  • [45] Galectin-9 regulates T helper cell function independently of Tim-3
    Su, Ee W.
    Bi, Shuguang
    Kane, Lawrence P.
    GLYCOBIOLOGY, 2011, 21 (10) : 1258 - 1265
  • [46] Galectin-9 ameliorates herpes simplex virus-induced inflammation through apoptosis
    Shim, Ju A.
    Park, Sun
    Lee, Eun-So
    Niki, Toshiro
    Hirashima, Mitsuomi
    Sohn, Seonghyang
    IMMUNOBIOLOGY, 2012, 217 (06) : 657 - 666
  • [47] Inhibition of Galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunity
    Sun, Xian
    Wang, Wei-Jan
    Lang, Jilu
    Yang, Riyao
    Shen, Wan-Jou
    Sun, Linlin
    Hsu, Jung-Mao
    Chan, Li-Chuan
    Li, Chia-Wei
    Xia, Weiya
    Ke, Baozhen
    Yao, Guodong
    Huang, Kebin
    Lee, Pei-Chih
    Koller, Paul B.
    Hung, Mien-Chie
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2023, 19 (14): : 4644 - 4656
  • [48] Peroxisome proliferator-activated receptor γ upregulates galectin-9 and predicts prognosis in intestinal-type gastric cancer
    Cho, Soo-Jeong
    Kook, Myeong-Cherl
    Lee, Jun Ho
    Shin, Ji-Young
    Park, JuRi
    Bae, Young-Ki
    Choi, Il Ju
    Ryu, Keun Won
    Kim, Young-Woo
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (04) : 810 - 820
  • [49] Galectin-9 promotes natural killer cells activity via interaction with CD44
    Rahmati, Amirhossein
    Bigam, Steven
    Elahi, Shokrollah
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [50] Galectin-9 expands immunosuppressive macrophages to ameliorate T-cell-mediated lung inflammation
    Arikawa, Tomohiro
    Saita, Naoki
    Oomizu, Souichi
    Ueno, Masaki
    Matsukawa, Akihiro
    Katoh, Shigeki
    Kojima, Keisuke
    Nagahara, Keiko
    Miyake, Minoru
    Yamauchi, Akira
    Kohrogi, Hirotsugu
    Hirashima, Mitsuomi
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2010, 40 (02) : 548 - 558